STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($) |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Oct. 25, 2024 |
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
| Common stock, shares authorized | 400,000,000 | 400,000,000 | 3,389,169 |
| Preferred stock, shares authorized | 50,000,000 | 50,000,000 | 28,467,564 |
| Preferred stock voting rights | Each share of Preferred Stock has the voting power of ten shares of Common Stock, and can at any time be converted into five, shares of Common Stock. The number of shares of Preferred Stock issued and outstanding during the reporting period(s). | ||
| Number of warrants issued | 15,383,334 | ||
| Weighted average exercise price | $ 0.15 | ||
| Warrant [Member] | |||
| Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
| Warrant awarded, shares | 50,000 | ||
| Warrant awarded | $ 21,606 | ||
| Warrants exercisable, weighted average remaining contractual life | 4 years 7 months 6 days | ||
| Warrants outstanding, aggregate intrinsic value | |||
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non options exercisable weighted average remaining contractual term 2. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by Share based payment award non options outstanding intrinsic value. No definition available.
|
| X | ||||||||||
- Definition Stock issued during period shares warrant issued. No definition available.
|
| X | ||||||||||
- Definition Stock issued during period value warrant issued. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The maximum number of common shares permitted to be issued by an entity's charter and bylaws. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Description of voting rights of nonredeemable preferred stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|